The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation
The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation
Regenerating bone tissue involves complex, temporal and coordinated signal cascades of which bone morphogenic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF165) play a prominent role. The aim of this study was to determine if the delivery of human bone marrow stromal cells (HBMSC) seeded onto VEGF165/BMP-2 releasing composite scaffolds could enhance the bone regenerative capability in a critical sized femur defect. Alginate-VEGF165/PDLLA-BMP-2 scaffolds were fabricated using a supercritical CO2 mixing technique and an alginate entrapment protocol. Increased release of VEGF165 (750.4 ± 596.8 ?g/ml) compared to BMP-2 (136.9 ± 123.4 ?g/ml) was observed after 7-days in culture. Thereafter, up till 28 days, an increased rate of release of BMP-2 compared to VEGF165 was observed. The alginate-VEGF165/PDLLA-BMP-2 + HBMSC group showed a significant increase in the quantity of regenerated bone compared to the alginate-VEGF165/PDLLA-BMP-2 and alginate/PDLLA groups respectively in a critical sized femur defect study as indices measured by ?CT. Histological examination confirmed significant new endochondral bone matrix in the HBMSC seeded alginate-VEGF165/PDLLA-BMP-2 defect group in comparison to the other groups. These studies demonstrate the ability to deliver a combination of HBMSC with angiogenic and osteogenic factors released from biodegradable scaffold composites enhances the repair and regeneration of critical sized bone defects.
1241-1250
Kanczler, Janos
eb8db9ff-a038-475f-9030-48eef2b0559c
Ginty, P.
b69ddbe7-9176-4bb0-9224-2f4e0b03ba6a
White, L.
67ad730f-e2c1-4e05-b79d-c2a9e55cabf5
Clarke, N.
76688c21-d51e-48fa-a84d-deec66baf8ac
Howdle, S.
116f2d16-cf5a-4c35-8587-f46e3f49ecf1
Shakesheff, K.
3a1e9a8e-8987-4ce0-a1a9-4f83b5702b96
Oreffo, R.
ff9fff72-6855-4d0f-bfb2-311d0e8f3778
February 2010
Kanczler, Janos
eb8db9ff-a038-475f-9030-48eef2b0559c
Ginty, P.
b69ddbe7-9176-4bb0-9224-2f4e0b03ba6a
White, L.
67ad730f-e2c1-4e05-b79d-c2a9e55cabf5
Clarke, N.
76688c21-d51e-48fa-a84d-deec66baf8ac
Howdle, S.
116f2d16-cf5a-4c35-8587-f46e3f49ecf1
Shakesheff, K.
3a1e9a8e-8987-4ce0-a1a9-4f83b5702b96
Oreffo, R.
ff9fff72-6855-4d0f-bfb2-311d0e8f3778
Kanczler, Janos, Ginty, P., White, L., Clarke, N., Howdle, S., Shakesheff, K. and Oreffo, R.
(2010)
The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation.
Biomaterials, 31 (6), .
(doi:10.1016/j.biomaterials.2009.10.059).
Abstract
Regenerating bone tissue involves complex, temporal and coordinated signal cascades of which bone morphogenic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF165) play a prominent role. The aim of this study was to determine if the delivery of human bone marrow stromal cells (HBMSC) seeded onto VEGF165/BMP-2 releasing composite scaffolds could enhance the bone regenerative capability in a critical sized femur defect. Alginate-VEGF165/PDLLA-BMP-2 scaffolds were fabricated using a supercritical CO2 mixing technique and an alginate entrapment protocol. Increased release of VEGF165 (750.4 ± 596.8 ?g/ml) compared to BMP-2 (136.9 ± 123.4 ?g/ml) was observed after 7-days in culture. Thereafter, up till 28 days, an increased rate of release of BMP-2 compared to VEGF165 was observed. The alginate-VEGF165/PDLLA-BMP-2 + HBMSC group showed a significant increase in the quantity of regenerated bone compared to the alginate-VEGF165/PDLLA-BMP-2 and alginate/PDLLA groups respectively in a critical sized femur defect study as indices measured by ?CT. Histological examination confirmed significant new endochondral bone matrix in the HBMSC seeded alginate-VEGF165/PDLLA-BMP-2 defect group in comparison to the other groups. These studies demonstrate the ability to deliver a combination of HBMSC with angiogenic and osteogenic factors released from biodegradable scaffold composites enhances the repair and regeneration of critical sized bone defects.
This record has no associated files available for download.
More information
Published date: February 2010
Organisations:
Dev Origins of Health & Disease
Identifiers
Local EPrints ID: 72896
URI: http://eprints.soton.ac.uk/id/eprint/72896
ISSN: 0142-9612
PURE UUID: 8f0b4a0c-5996-43d6-8ffd-32a2f330b883
Catalogue record
Date deposited: 24 Feb 2010
Last modified: 14 Mar 2024 02:50
Export record
Altmetrics
Contributors
Author:
Janos Kanczler
Author:
P. Ginty
Author:
L. White
Author:
S. Howdle
Author:
K. Shakesheff
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics